Global Med Technologies to Report Second Quarter Financial Results on Tuesday, August 12, 2008
Conference Call to Follow Release

The replay of this call is no longer available.

Global Med Technologies®, Inc. (“Global Med” or the “Company”) (OTCBB:GLOB), an international e-Health, medical information technology company, will report its second quarter financial results on Tuesday, August 12, 2008, after the market closes. The Company will host a conference call at 4:30 p.m. EDT on the same day.

Conference Call Details:

Dr. Mick Ruxin, Chief Executive Officer, Tom Marcinek, President and Chief Operating Officer, and Darren Craig, Vice President of Finance, will discuss the second quarter financial results and will be available to answer questions. The one-hour conference call will be held on Tuesday, August 12, 2008, at 4:30 p.m. EDT.

Interested parties are welcome to call the telephone numbers listed below five minutes prior to the start of the conference call. Callers within the U.S. should call: 1-866-789-9224. Callers that are outside of the U.S. should call: 1-706-679-9621. Callers should reference "Global Med Second Quarter Financial Results" to the conference call operator. The conference call ID number will be: 58996634.

 An automated replay of the conference call will be available from August 12, 2008 at 5:30 p.m. EDT until August 14, 2008 at 11:59 p.m. EDT. To access the replay, callers within the U.S. should call: 1-800-642-1687. Callers outside of the U.S. should call: 1-706-645-9291 and enter Global Med’s access code of 58996634.

The replay of the conference call will be available from August 14, 2008 onward at Global Med’s website at www.globalmedtech.com.

About Global Med Technologies, Inc.

Global Med Technologies®, Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med’s products are deployed in 20 countries and serve over 1,400 transfusion centers, blood banks and laboratories.

Global Med’s U.S. division, Wyndgate Technologies®, provides Vein-to-Vein® tracking through its Donor Doc™, SafeTrace®, SafeTrace Tx® and ElDorado Donor™ software products. Each year, Wyndgate’s products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply.

Global Med’s European subsidiary, Inlog, SA, is a leading provider of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog’s products include EdgeBlood**, EdgeTrack**, EdgeCell, EdgeLab and SAPA.

Global Med’s U.S. division , eDonor® , provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor’s products and services are designed to complement Global Med’s strong line of international blood management and laboratory information software and service solutions.

Global Med’s U.S. subsidiary, PeopleMed®, Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.